For instance, our analysis highlighted markers such as lncRNA-EXOC7, which exhibited pronounced fold-changes, ranging from 2.93- to 3.18-fold elevations in cervical cancer patients relative to healthy controls. This evidence concerns the gene EXOC7 and cervical cancer.